Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung

Detalles Bibliográficos
Autor principal: Intelligence and Neuroscience, Computational
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371573/
https://www.ncbi.nlm.nih.gov/pubmed/37502038
http://dx.doi.org/10.1155/2023/9879124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371573/
https://www.ncbi.nlm.nih.gov/pubmed/37502038
http://dx.doi.org/10.1155/2023/9879124

Ejemplares similares